RxDoctor Payments Data

Mark Nichols, MD

Otology & Neurotology · Houston, TXNPI 1215910732

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,738 of the $4,538 with a category attached, or 82.4%. 15 manufacturers reported payments, led by Cochlear Americas at 33.9% of the total. Reporting peaked in 2022 at $1,401 and has fallen 59.2% since, to $572 in 2025.

$4,538in general payments, 2019–2025

Across 42 payments — averaging $108.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cochlear Americas$2K
  • Aerin Medical Inc.$690
  • Acclarent, Inc$480
  • Optinose US, Inc.$391
  • Sanofi$247
  • Intersect ENT, Inc.$241
  • plus $950 from 9 others

What the payments were for

  • Consulting fees$80018%
  • Food & beverage$3,73882%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,538 in reported general payments places this provider in the 80th percentile of 33 otology & neurotology providers in Texas.

See all otology & neurotology providers in Texas

Medicare billing

Part B allowed, 2024
$195,935
Medicare patients
698
Services billed
2,608

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluticasone Propionate345$8,958
Ipratropium Bromide62$4,627
Azelastine Hcl94$4,447
Omeprazole174$3,149
Pantoprazole Sodium102$2,246
Fluocinolone Acetonide Oil31$1,967
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth14$1,680
Tobramycin-DexamethasoneTobramycin/Dexamethasone26$1,178
Esomeprazole Magnesium15$946
Mometasone Furoate22$941
Ofloxacin69$817
CefuroximeCefuroxime Axetil30$641
Acetic Acid21$640
Doxycycline Hyclate69$637
Montelukast Sodium52$632

Paid to pharmacies, not to this prescriber.

Other otology & neurotology in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →